- Has received chemotherapy or immunotherapy (including targeted therapy with antibody or small molecule, retinoid therapy, and hormonal therapy) within 4 weeks (28 days) of the start of study treatment ( or within 12 weeks for anti CCR4 antibody or anti CD20 antibody).